Select company
- Ticker/CompanyMarket Cap.
No results found
Select metric
Pick a metric...
-425.15%Return on Equity
VS
Market
Sector
Industry
History
$ 2.02Close
$ 0.25 - $ 3.64 52-Week Range
Ticker Information
Ticker
RLMDCompany Name
RELMADA THERAPEUTICS INCSector
HealthcareIndustry
BiotechnologyExchange
NASDAQRELMADA THERAPEUTICS INC - Return on Equity Chart Analysis (TTM)
From
Zoom
1Y
3Y
5Y
10Y
RLMD - ROE Historical data
| Date | Shareholders Equity | Net Income Common Stock | Return on Equity |
|---|---|---|---|
| 6/30/2025 | $ 15.95M | $ -67.81M | -425.15% |
| 3/31/2025 | $ 22.44M | $ -75.71M | -337.38% |
| 12/31/2024 | $ 35.52M | $ -79.98M | -225.15% |
| 9/30/2024 | $ 47.63M | $ -86.49M | -181.6% |
| 6/30/2024 | $ 61.49M | $ -86.76M | -141.1% |
| 3/31/2024 | $ 72.05M | $ -94.3M | -130.89% |
| 12/31/2023 | $ 85.36M | $ -98.79M | -115.74% |
| 9/30/2023 | $ 100.73M | $ -111.57M | -110.77% |
| 6/30/2023 | $ 111.34M | $ -128.99M | -115.85% |
| 3/31/2023 | $ 125.47M | $ -143.62M | -114.47% |
Key Performance Insights, Last 5 Years
- RELMADA THERAPEUTICS INC's latest trailing twelve months (TTM) ROE stands at -35.37%.
- Over the past 5 years, RELMADA THERAPEUTICS INC's average ROE has been -136.17%.
- The median ROE for RELMADA THERAPEUTICS INC during this period was -113.15%
- RELMADA THERAPEUTICS INC reached its highest ROE over the past 5 years at -35.37%.
- The lowest ROE recorded by RELMADA THERAPEUTICS INC in the same timeframe -425.15%
Similar metrics to ROE:
- Net Income Common Stock - [Income Statement] The company's Net Income (loss) [NetInc] less the sum paid on dividends of preferred shares [PrefDivIS].
- Return on Assets - [Calculation] Return on Assets (ROA) measures net income [NetIncCmn] as percentage of total [Assets]. A high ROA shows an effective allocation of capital by the company.
- Shareholders Equity - [Balance Sheet] A principal component of the balance sheet; in addition to [Liabilities] and [Assets]; that represents the total of all stockholders' equity (deficit) after all liabilities have been deducted.
- Net Margin - [Calculation] A company’s Net Income [NetIncCmn] as a percentage of [Revenue]. Measures how much earnings a company produces for each dollar of revenue generated.
- Return on Invested Capital - [Calculation] Return on Invested Capital (ROIC) measures how well a company allocates its invested capital to profitable projects and/or investments. It is calculated as net income [NetIncCmn] divided by invested capital [InvCapital].
Definition of Return on Equity
[Calculation] Return on Equity (ROE) measures net income [NetIncCmn] as percentage of [Equity]. A high ROE shows an effective use of investor capital, but it doesn't consider any risks related to financial leverage [Debt].Net Inc. Cmn. / Equity
(=) ROE ROE for RELMADA THERAPEUTICS INC is calculated as follows: Net Inc. Cmn. [ $ -43.22M ] / Equity [ $ 122.21M ]
(=) ROE [ -35.37% ] RLMD - Return on Equity, Last 5 years
-425.15%
Minimum
Jun 30, 2025
-35.37%
Maximum
Sep 30, 2020
-136.17%
Average
-113.15%
Median
ROE Benchmark AnalysisMarket
The chart above depicts the distribution of ROE for companies in the Total Stock Market. The average ROE of the companies is 1.63% with a standard deviation of 22.52%.
The following table provides additional summary stats:
ROE in the Market:
| filtered constituents | 3.13K |
|---|---|
| min | -66.24% |
| max | 73.25% |
| average | 1.63% |
| median | 6.53% |
| std | 22.52% |